SOURCE: Leerink Swann and Company

May 18, 2005 11:46 ET

Leerink Swann & Company Initiates Coverage of Invitrogen Corporation (NASDAQ: IVGN)

BOSTON, MA -- (MARKET WIRE) -- May 18, 2005 -- This morning, Senior Biotechnology Analyst John Sullivan initiated coverage of Invitrogen Corporation (NASDAQ: IVGN) with a Market Perform rating.

About Invitrogen Corporation

Invitrogen Corporation provides products and services that support academic and government research institutions, and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bio-production. The company is headquartered in Carlsbad, California.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564